References
- Greer JP, Arber DA, Glader B, et al. Thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. In: Borgna-Pignatti C, Galanello C, Editors. Wintrobe’s Clinical Hematology, 13th Ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins. 2014:862–912.
- Muncie HL Jr, Campbell J. α And β thalassemia. Am Fam Physician. 2009;80(4):339–344.
- Thalassemia International Federation: guidelines for the clinical management of thalassemia, 2nd ed. 2008. Available from: http://www.thalassemia.org.cy
- Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford, Oxfordshire, UK: Blackwell Science Ltd., 2001.
- Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the hemoglobinopathies. Bailliére’s Clin Haematol. 1998;11(1):1–50.
- Vichinsky EP. Changing patterns of thalassemia worldwide. Ann NY Acad Sci. 2005;1054:18–24.
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6)480–487.
- Skarmoutsou C, Papassotiriou I, Traeger-Synodinos J, et al. Erythroid bone marrow activity and red cell hemoglobinization in iron-sufficient β-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin content. Correlation with genotypes and Hb A2 levels. Haematologica. 2003;88(6):631–636.
- Cheung YF, Chow PC, Chan GC, Ha SY. Carotid intima-media thickness is increased and related to arterial stiffening in patients with β-thalassaemia major. Br J Haematol. 2006;135(5):732–734.
- Cappellini M, Cohen A, Eleftheriou A, et al. Guidelines for the clinical management of thalassemia, 2nd revised edition. Nicosia, Cyprus: Thalassemia International Federation, 2008.
- Iraqi Federal Board of Supreme Audit – Performance Evaluation Reports. [cited 2016 Aug 21]. Available from: http://www.d-raqaba-m.iq/pages_ar/repo_performance_ar.aspx.
- Report of a Joint WHO-TIF Meeting on the Management of Hemoglobin Disorders held at Nicosia, Cyprus, [cited 2007 Nov 16-18]. Available from: http://apps.who.int/iris/handle/10665/43969
- Modell B, Khan M, Darlison M. Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000;355(9220):2051–2052.
- Angastiniotis M, Vives Corrons JL, Soteriades ES, Eleftheriou A. The impact of migration on the health services for rare diseases in Europe: the example of haemoglobin disorders. ScientificWorldJournal. 2013;2013:727905.
- Modell B, Darlison M, Birgens H, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest. 2007;67(1):39–69.
- Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ. 2004;329(7475):1134–1137.
- Republic of Iraq: Iraq Family Health Survey 2006/7. World Health Organization, Regional Office for Eastern Mediterranean, [cited 2017 Jan 11]. Available from: http://www.emro.who.int/iraq/pdf/ifhs_report_en.pdf.
- Alkindi S, Al Zadjali S, Al Madhani A, et al. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin. 2010;34(2):135–144.
- Mahmoud RA, El-Mazary AA, Khodeary A. Seroprevalence of hepatitis C, hepatitis B, cytomegalovirus, and human immunodeficiency viruses in multitransfused thalassemic children in Upper Egypt. Adv Hematol. 2016;2016:9032627.
- Khorasani G, Kosaryan M, Vahidshahi K, et al. Results of the national program for prevention of β-thalassemia major in the Iranian governorate of Mazandaran. Hemoglobin. 2008;32(3):263–271.
- Cao A, Galanello R. 2002. Effect of consanguinity on screening for thalassemia. N Engl J Med. 2002;347(15):1200–1202.
- Lawson SE, Roberts IA, Amrolia P, et al. Bone marrow transplantation for β-thalassemia major: the UK experience in two paediatric centres. Br J Haematol. 2003;120(2):289–295.
- Al-Sheyyab M, Batieha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multi-transfused patients. J Trop Pediatr. 2001;47(4):239–242.
- Rahman M, Lodhi Y. Prospects and future of conservative management of β thalassemia major in a developing country. Pak J Med Scie. 2004;20(2):105–112.
- Al-Naamani K, Al-Zakwani I, Al-Sinani S, et al. Prevalence of hepatitis C among multi-transfused thalassaemic patients in Oman. Sultan Qaboos Univ Med J. 2015;15(1):e46–e51.
- Irshad M, Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol. 2002;21(5):183–184.
- Al-Allawi NA, Jalal SD, Mohammad AM, et al. β-Thalassemia intermedia in Northern Iraq: a single center experience. Biomed Res Int. 2014;2014:262853. doi: 10.1155/2014/262853.
- Tareef FR, Salwa SAW, Hadeer NA. Prevalence of hepatitis C among patients with Β thalassemia in Diyala, Iraq. Iraqi Acad Sci J. 2011;24(4):113–120.